UnitedHealth Raises 2026 EPS Guidance After Medical Cost Improvements
Dow Jones10-13 19:43
UnitedHealth Group now expects full-year 2026 adjusted EPS of at least $20.50, up from prior guidance, after third-quarter results showed improved medical cost management. The company's medical cost ratio fell to 88.4% from 89.9% a year earlier, reflecting benefit design changes, pricing discipline and care delivery enhancements. The operating cost ratio also dropped to 12.8% from 13.5% in the year-ago period. Third-quarter adjusted EPS came in at $4.69, compared with $2.92 in the same quarter last year
This article was automatically created using artificial-intelligence technology and reviewed by Dow Jones Newswires editors.
At the request of the copyright holder, you need to log in to view this content
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments